BioSpace News Archive

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced the launch of a proposed underwritten public offering by the Company of 2,000,000 shares of its Class A common stock pursuant to an existing shelf registration statement.

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced an update to its fourth quarter and fiscal year 2020 revenue guidance given on November 4, 2020.

BioCryst Pharmaceuticals, Inc. announced that the compensation committee of BioCryst’s board of directors granted 13 newly-hired employees inducement options to purchase an aggregate of 260,500 shares of BioCryst common stock on November 30, 2020 as inducements material to each employee entering into employment with BioCryst.

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced the commencement of an underwritten public offering of 1,511,546 American Depositary Shares

Montefiore Medical Center is notifying some patients about a privacy breach involving patient information accessed illegally by a former employee.

Thermo Scientific Neoma Multicollector ICP-MS extracts reliable isotopic data from even the smallest samples, with new levels of sensitivity, accuracy and productivity

Codagenix Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, announced today the completion of dosing in a Phase 1 clinical trial of its live attenuated CodaVax™-RSV vaccine, an intranasally-administered vaccine for the prevention of respiratory syncytial virus (RSV).

Rhinostics Inc. (www.rhinostics.com), an early stage company founded by two Harvard professors to provide automated sample collection solutions for more efficient laboratory workflows, announces the appointment of Cheri Walker as President and Chief Executive Officer.

Company Appoints Healthcare Industry Veteran Stacy Boetto to Lead Patient Care and Coordination

Merz Therapeutics today announced Health Canada’s notice of compliance for XEOMIN® (incobotulinumtoxinA) for the treatment of chronic sialorrhea, or excessive drooling, associated with neurological disorders in adult patients